Stock Mumak

Stock Profile

Johnson

Thanks to a strong pipeline, robust cash flows and a defensive business model, Johnson & Johnson remains a high-quality healthcare investment.

Stock Snapshot

JNJ Logo
Table HeaderTable Header
CompanyJohnson & Johnson
SectorHealthcare
ThemePharma & Medical Technology
Business ModelDevelopment and marketing of innovative pharmaceuticals and medical technology
ISINUS4781601046
Market Capitalizationapprox. USD 616.0 billion
UMBRELLA StatusActive

UMBRELLA History

The key milestones of Johnson & Johnson within the UMBRELLA Strategy.

September 22, 2026
↓
Reduction

Healthcare weighting reduced

October 2, 2026
↓
Reduction

Position reduced toward 9%

October 6, 2026
↓
Reduction

Position reduced further

Latest Developments

↓
Reduction
October 6, 2026

Position reduced further

The weighting was reduced from approximately 8.9% to 6.3% – a reduction of around 29% compared with the previous position size.

↓
Reduction
October 2, 2026

Position reduced toward 9%

↓
Reduction
September 22, 2026

Healthcare weighting reduced

Following strong performance, a larger portion of the position was sold for the first time.

Price Performance (12 Months)

Aktuelle Unternehmensmeldungen

Johnson
Healthcare

Valuation Analysis: Johnson & Johnson

ISIN: US4781601046

Johnson & Johnson is one of the world’s leading healthcare companies. The company benefits from a strong position in pharmaceuticals and medical technology, a robust innovation pipeline, and an exceptionally solid balance sheet.
Active icon

Latest Portfolio Updates

Weekly Update

Weekly Market Overview – October 12–October 18, 2026

Defense back in focus, Alphabet gains significance, and the healthcare sector takes the lead: The UMBRELLA Strategy realigns its portfolio
Next Update
Strategy in Action

Alphabet – Position Further Increased

The UMBRELLA strategy further increases its Alphabet position. The focus is on the growth potential of artificial intelligence, Google Cloud,
Next Update
Weekly Update

Weekly Market Overview – October 5–October 11, 2026

Palantir becomes the largest UMBRELLA position. SpaceX gains, Dell is added, and Bayer exits. The focus on AI and technology
Next Update
MUMAK SpotLight

MUMAK Spotlight of the week: SpaceX takes the lead – Technology rotation continues

SpaceX becomes the largest position, Palantir gains weight, and Dell Technologies is newly added to the UMBRELLA Strategy.
Next Update
All Portfolio Updates